🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anl...
Status
Recruiting
Location
Jiangxi Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05252078
Treatments Being Tested
This is An Open, Single Arm, Multicenter, Exploratory Phase II study, to ev...
Status
Unknown
Location
Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)
Start Date
2022-01-06
Trial ID
NCT05111366
Treatments Being Tested
Overall, although there are many options for second-line treatment of liver...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2024-07-20
Trial ID
NCT06475287
Treatments Being Tested
TQB2450 is a humanized monoclonal antibody targeting programmed death ligan...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-06-24
Trial ID
NCT03996408
To assess the efficacy and safety of TQB2450 in combination with anlotinib ...
Status
Unknown
Location
Cancer Hospital Affiliated to Shandong First Medical University
Start Date
2023-05-30
Trial ID
NCT05942508
Treatments Being Tested
Based on the above situation, the investigators propose the following scien...
Status
Recruiting
Location
Tenth People's Hospital of Tongji University
Start Date
2025-04-21
Trial ID
NCT06914297
Treatments Being Tested
Objective to compare the efficacy and safety of TQB2450 injection combined ...
Status
Recruiting
Location
The Central People's Hospital of Huizhou
Start Date
2023-04-12
Trial ID
NCT06141226
Treatments Being Tested
TQB2450 is a humanized monoclonal antibody targeting programmed death ligan...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-03
Trial ID
NCT04306926
In this study, single cell transcriptome sequencing will be performed on th...
Status
Unknown
Location
Chinese Academy of Medical Sciences
Start Date
2021-04-30
Trial ID
NCT04888546
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled phase III clin...
Status
Not Yet Recruiting
Location
Anhui Provincial Hospital
Start Date
2024-09
Trial ID
NCT06469879
Treatments Being Tested